Acute myocarditis in children

References

• Wakafuji S, Okada R. Twenty year autopsy statistics of myocarditis incidence in Japan. Jpn Circ. J.50(12), 1288–1293 (1986).
   PubMedGoogle Scholar
• Carniel E, Sinagra G, Bussani R et al. Fatal myocarditis: morphologic and clinical features. Ital. Heart J.5(9), 702–706 (2004).
   PubMedGoogle Scholar
• Kyto V, Saraste A, Voipio-Pulkki LM, Saukko P. Incidence of fatal myocarditis: a population-based study in Finland. Am. J. Epidemiol.165(5), 570–574 (2007).
   PubMed Web of Science ®Google Scholar
• Weber MA, Ashworth MT, Risdone RA et al. Clinicopathological features of paediatric deaths due to myocarditis: an autopsy series. Arch. Dis. Child.93(7), 594–598 (2008).
   PubMed Web of Science ®Google Scholar
• Doolan A, Langlois N, Semsarian C. Causes of sudden death in young Australians. Med. J. Aust.180(3), 110–112 (2004).
   PubMed Web of Science ®Google Scholar
• Freedman SB, Haladyn JK, Floh A, Kirsh JA, Taylor G, Thull-Freedman J. Pediatric myocarditis: emergency department clinical findings and diagnostic evaluation. Pediatrics120(6), 1278–1285 (2007).
   PubMed Web of Science ®Google Scholar
• Lipshultz SE, Sleeper LA, Towbin JA et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N. Engl. J. Med.348(17), 1647–1655 (2003).
   PubMed Web of Science ®Google Scholar
• Daubeney PE, Nugent AW, Chondros P et al. National Australian Childhood Cardiomyopathy Study. Clinical features and outcomes of childhood dilated cardiomyopathy: results from a national population-based study. Circulation114(24), 2671–2678 (2006).
   PubMed Web of Science ®Google Scholar
• Towbin JA, Lowe AM, Colan SD et al. Incidence, causes, and outcomes of dilated cardiomyopathy. JAMA296(15), 1867–1876 (2006).
   PubMed Web of Science ®Google Scholar
• Kane DA, Fulton DR, Saleeb S, Zhou J, Lock JE, Geggel RL. Needles in hay: chest pain as the presenting symptom in children with serious underlying cardiac pathology. Congenit. Heart Dis.5(4), 366–373 (2010).
   PubMed Web of Science ®Google Scholar
• Kim HJ, Yoo GH, Kil HR. Clinical outcome of acute myocarditis in children according to treatment modalities. Korean J. Pediatr.53(7), 745–752 (2010).
   PubMedGoogle Scholar
• English RF, Janosky JE, Ettedgui JA, Webber SA. Outcomes for children with acute myocarditis. Cardiol. Young14(5), 488–493 (2004).
   PubMed Web of Science ®Google Scholar
• Mahrholdt H, Wagner A, Deluigi CC et al. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation114(15), 1581–1590 (2006).
   PubMed Web of Science ®Google Scholar
• Monney PA, Sekhri N, Burchell T et al. Acute myocarditis presenting as acute coronary syndrome: role of early cardiac magnetic resonance in its diagnosis. Heart DOI: 10.1136/hrt.2010.204818 (2010) (Epub ahead of print).
   PubMedGoogle Scholar
• Drossner DM, Hirsh DA, Sturm JJ et al. Cardiac disease in pediatric patients presenting to a pediatric ED with chest pain. Am. J. Emerg. Med. DOI: 10.1016/j.ajem.2010.01.011 (2010) (Epub ahead of print).
   PubMedGoogle Scholar
• Durani Y, Egan M, Baffa J, Selbst SM, Nager AL. Pediatric myocarditis: presenting clinical characteristics. Am. J. Emerg. Med.27(8), 942–947 (2009).
   PubMed Web of Science ®Google Scholar
• Felker GM, Boehmer JP, Hruban RH et al. Echocardiographic findings in fulminant and acute myocarditis. J. Am. Coll. Cardiol.36(1), 227–232 (2000).
   PubMed Web of Science ®Google Scholar
• Ramachandra G, Shields L, Brown K, Ramnarayan P. The challenges of prompt identification and resuscitation in children with acute fulminant myocarditis: case series and review of the literature. J. Paediatr. Child Health46(10), 579–582 (2010).
   PubMed Web of Science ®Google Scholar
• Gupta S, Markham DW, Drazner MH, Mammen PP. Fulminant myocarditis. Nat. Clin. Pract. Cardiovasc. Med.5(11), 693–706 (2008).
   PubMedGoogle Scholar
• Sezai H, Hata M, Niino T et al. Mechanical circulatory support for fulminant myocarditis. Surg. Today38(9), 773–777 (2008).
   PubMed Web of Science ®Google Scholar
• Amabile N, Fraisse A, Bouvenot J, Chetaille P, Ovaert C. Outcome of acute fulminant myocarditis in children. Heart92(9), 1269–1273 (2006).
   PubMed Web of Science ®Google Scholar
• Cooper LT Jr. Acute heart failure due to fulminant and giant cell myocarditis. Herz31(8), 767–770 (2006).
   PubMed Web of Science ®Google Scholar
• Soongswang J, Durongpisitkul K, Laohaprasittiporn D et al. Cardiac troponin T: a marker in the diagnosis of acute myocarditis in children. Pediatr. Cardiol.26(1), 45–49 (2005).
   PubMed Web of Science ®Google Scholar
• Al-Biltagi M, Issa M, Hagar HA, Abdel-Hafez M, Aziz NA. Circulating cardiac troponins levels and cardiac dysfunction in children with acute and fulminant viral myocarditis. Acta Paediatr.99(10), 1510–1516 (2010).
   PubMed Web of Science ®Google Scholar
• Levi D, Alejos J. Diagnosis and treatment of pediatric viral myocarditis. Curr. Opin. Cardiol.16(2), 77–83 (2001).
   PubMed Web of Science ®Google Scholar
• Aretz HT, Billingham ME, Edwards WD et al. Myocarditis. A histopathologic definition and classification. Am. J. Cardiovasc. Pathol.1(1), 3–14 (1987).
   PubMedGoogle Scholar
• Mahrholdt H, Goedecke C, Wagner A et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation109(10), 1250–1258 (2004).
   PubMed Web of Science ®Google Scholar
• Schultz JC, Hilliard AA, Cooper LT Jr, Rihal CS. Diagnosis and treatment of viral myocarditis. Mayo Clin. Proc.84(11), 1001–1009 (2009).
   PubMed Web of Science ®Google Scholar
• Cooper LT, Baughman KL, Feldman AM et al. The role of endomyocardial biopsy in the management of cadiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. J. Am. Coll. Cardiol.50(19), 1914–1931 (2007).
   PubMed Web of Science ®Google Scholar
• Baughman K. Diagnosis of myocarditis: death of Dallas criteria. Circulation113(4), 593–595 (2006).
   PubMed Web of Science ®Google Scholar
• Andreoletti L, Leveque N, Boulagnon C, Brasselet C, Fornes P. Viral causes of human myocarditis. Arch. Cardiovasc. Dis.102(6–7), 559–568 (2009).
   PubMed Web of Science ®Google Scholar
• Sparrow PF, Merchant N, Provost YL, Doyle DF, Nguyen ET, Paul NS. CT and MR imaging in patients with aquired heart disease at risk for sudden cardiac death. Radiographics29(3), 805–823 (2009).
   PubMed Web of Science ®Google Scholar
• Friedrich MG, Sechtem U, Schulz-Menger J et al. Cardiovascular magnetic resonance in myocarditis: a JACC white paper. J. Am. Coll. Cardiol.53(17), 1475–1487 (2009).
   PubMed Web of Science ®Google Scholar
• Gagliardi MG, Bevilacqua M, Di Renzi P, Passariello R, Marcelletti C. Usefulness of magnetic resonance imaging for diagnosis of acute myocarditis in infants and children, and comparison with endomyocardial biopsy. Am. J. Cardiol.68(10), 1089–1091 (1991).
   PubMed Web of Science ®Google Scholar
• Mivelaz Y, Sekarski N, Qanadli SD, Meijboom EJ, Di Bernardo S. A noninvasive diagnostic tool to differentiate myocarditis from myocardial infarction: late gadolinium enhanced cardiac magnetic resonance. Eur. J. Pediatr.166(9), 971–972 (2007).
   PubMed Web of Science ®Google Scholar
• Calabrese F, Carturan E, Thiene G. Cardiac infections: focus on molecular diagnosis. Cardiovasc. Pathol.19(3), 171–182 (2010).
   PubMed Web of Science ®Google Scholar
• Camargo PR, Okay TS, Yamamoto L, Del Negro GM, Lopes AA. Myocarditis in children and detection of viruses in myocardial tissue: implications for immunosuppressive therapy. Int. J. Cardiol.148(2), 204–208 (2009).
   PubMed Web of Science ®Google Scholar
• Kuhl U, Pauschinger M, Seeberg B et al. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation112(13), 1965–1970 (2005).
   PubMed Web of Science ®Google Scholar
• Gross ER, Gander JW, Reichstein A, Cowles RA, Stolar CJ, Middlesworth W. Fulimant pH1N1–09 influenza-associated myocarditis in pediatric patients. Pediatr. Crit. Care Med.12(2), e99–e101 (2011).
   Google Scholar
• Greaves K, Oxford JS, Price CP, Clarke GH, Crake T. The prevalence of myocarditis and skeletal muscle injury during acute viral infection in adults: measurement of cardiac troponins I and T in 152 patietns with acute influenza infection. Arch. Intern. Med.163(2), 165–168 (2003).
   PubMed Web of Science ®Google Scholar
• Renko M, Leskinen M, Kontiokari T, Tapiainen, Hedberg P, Uhari M. Cardiac troponin-I as a screening tool for myocarditis in children hospitalized for viral infection. Acta Paediatr.99(2), 283–285 (2010).
   PubMed Web of Science ®Google Scholar
• Omura T, Yoshiyama M, Hayashi T et al. Core protein of hepatitis C virus induces cardiomyopathy. Circ. Res.96(2), 148–150 (2005).
   PubMed Web of Science ®Google Scholar
• Matsumori A, Shimada T, Chapman NM, Tracy SM, Mason JW. Myocarditis and heart failure associated with hepatitis C virus infection. J. Card. Fail.12(4), 293–298 (2006).
   PubMed Web of Science ®Google Scholar
• Khunnawat C, Mukerji S, Havlichek D, Touma R, Abela GS. Cardiovascular manifestations in human immunodeficiency virus-infected patients. Am. J. Cardiol.102(5), 635–642 (2008).
   PubMed Web of Science ®Google Scholar
• Barbaro G. Heart and HAART: two sides of the coin for HIV-associated cardiology issues. World J. Cardiol.2(3), 53–57 (2010).
   PubMedGoogle Scholar
• Suesaowalak M, Cheung, MM, Tucker D, Chang AC, Chu J, Arrieta A. Chlamydophilia pneumoniae myopericarditis in a child. Pediatr. Cardiol.30(3), 336–339 (2008).
   PubMed Web of Science ®Google Scholar
• Costello JM, Alexander ME, Greco KM, Perez-Atayde AR, Laussen PC. Lyme carditis in children: presentation, predictive factors, and clinical course. Pediatrics123(5), 835–841 (2009).
   Google Scholar
• Haddad F, Berry G, Doyle RL, Martineau P, Leung TK, Racine N. Active bacterial myocarditis: a case report and review of the literature. J. Heart Lung Transplant.26(7), 745–749 (2007).
   PubMed Web of Science ®Google Scholar
• Blum JA, Zellweger MJ, Burri C, Hatz C. Cardiac involvement in African and American trypanosomiasis. Lancet Infect. Dis.8(10), 631–641 (2008).
   PubMed Web of Science ®Google Scholar
• Girones N, Fresno M. Etiology of Chagas disease myocarditis: autoimmunity, parasite persistence, or both? Trends Parasitol.19(1), 19–22 (2003).
   PubMed Web of Science ®Google Scholar
• Rassi A Jr, Rassi A, Marin-Neto JA. Chagas heart disease: pathophysiologic mechanisms, prognostic factors, and risk stratification. Mem. Inst. Oswaldo. Cruz.104(Suppl. 1), 152–158 (2009).
   PubMed Web of Science ®Google Scholar
• Beghetti M, Wilson GJ, Bohn D, Benson L. Hypersensitivity myocarditid caused by an allergic reaction to cefaclor. J. Pediatr.132(1), 172–173 (1998).
   PubMed Web of Science ®Google Scholar
• Bhogal N, Grady AM, Ursell PC, Collins KK, Hornberger LK. Hypersensitivity myocarditis presenting as atrioventricular block and wide complex tachycardia in a toddler. Congenit. Heart Dis.3(5), 359–364 (2008).
   PubMedGoogle Scholar
• Ginsberg F, Parrillo JE. Eosinophilic myocarditis. Heart Fail. Clin.1(3), 419–429 (2005).
   PubMedGoogle Scholar
• Barton M, Finkelstein Y, Opavsky MA et al. Eosinophilic myocarditis temporally associated with conjugate meningococcal C and hepatitis B vaccines in children. Pediatr. Infect. Dis. J.27(9), 831–835 (2008).
   PubMed Web of Science ®Google Scholar
• Neumann T, Manger B, Schmid M et al. Cardiac involvement in Churg–Strauss syndrome: impact of endomyocarditis. Medicine88(4), 236–243 (2009).
   PubMed Web of Science ®Google Scholar
• Appenzeller S, Pineau CA, Clarke A. Acute lupus myocarditis: clinical features and outcome. Lupus DOI: 10.1177/0961203310395800 (2011) (Epub ahead of print).
   PubMedGoogle Scholar
• Esfandiarei M, McManus BM. Molecular biology and pathogenesis of viral myocarditis. Annu. Rev. Pathol. Mech. Dis.3, 127–155 (2008).
   PubMed Web of Science ®Google Scholar
• Tavares PS, Rocon-Albuquerque R Jr, Leite-Moreira AF. Innate immune receptor activation in viral myocarditis: pathophysiologic implications. Rev. Port. Cardiol.29(1), 57–78 (2010).
   PubMedGoogle Scholar
• Kuhl U, Schultheiss HP. Viral myocarditis: diagnosis, aetiology, and management. Drugs69(10), 1287–1302 (2009).
   PubMed Web of Science ®Google Scholar
• Caforio A, Tona F, Bottaro S et al. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy. Autoimmunity41(1), 35–45 (2008).
   PubMed Web of Science ®Google Scholar
• Chang H, Hanawa H, Yoshida T et al. Alteration of IL-17 related protein expression in experimental autoimmune myocarditis and inhibition of IL-17 by IL-10-Ig fusion gene transfer. Circ. J.72(5), 813–819 (2008).
   PubMed Web of Science ®Google Scholar
• Li Y, Heuser JS, Cunningham LC, Kosanke SD, Cunningham MW. Mimicry and antibody-mediated cell signaling in autoimmune myocarditis. J. Immunol.177(11), 8234–8240 (2006).
   PubMed Web of Science ®Google Scholar
• Mascaro-Blanco A, Alvarez K, Yu X et al. Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies. Autoimmunity41(6), 1–12 (2008).
   PubMed Web of Science ®Google Scholar
• Saito S, Hiroi Y, Zou Y et al. β-adrenergic pathway induces apoptosis through calcineurin activation in cardiac myocytes. J. Biol. Chem.275(44), 34528–34533 (2000).
   PubMed Web of Science ®Google Scholar
• Shizukuda Y. Buttrick PM, Geenen DL, Borczuk AC, Kitis RN, Sonnenblick EH. β-adrenergic stimulation causes cardiocyte apoptosis: influence of tachycardia and hypertrophy. Am. J. Physiol. Heart Circ. Physiol.275, 961–968 (1998).
   PubMed Web of Science ®Google Scholar
• Zhang P, Cox CJ, Alvarez KM, Cunningham MW. Cutting edge: cardiac myosin activates innate immune responses through TLRs. J. Immunol.183, 27–31 (2009).
   PubMed Web of Science ®Google Scholar
• Yuan J, Cao AL, Yu M et al. Th17 cells facilitate the humoral immune response in patients with acute viral myocarditis. J. Clin. Immunol.30(2), 226–234 (2010).
   PubMed Web of Science ®Google Scholar
• Daniels MD, Hyland KV, Wang K, Engman DM. Recombinant cardiac myosin fragments induces experimental autoimmune myocarditis via activiation of Th1 and Th17 immunity. Autoimmunity41(6), 490–499 (2008).
   PubMed Web of Science ®Google Scholar
• Klugman D, Berger JT, Sable CA, He J, Khandelwal SG, Slonim AD. Pediatric patients hospitalized with myocarditis: a multi-instutional analysis. Pediatr. Cardiol.31(2), 222–228 (2010).
   PubMed Web of Science ®Google Scholar
• McNamara DM, Holubkov R, Starling RC et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation103(18), 2254–2259 (2001).
   PubMed Web of Science ®Google Scholar
• Mason JW, O’Connell JB, Herskowitz A et al. A clinical trial of immunosuppressive therapy for myocarditis. N. Engl. J. Med.333(5), 269–275 (1995).
   PubMed Web of Science ®Google Scholar
• Frustaci A, Russo MA, Chimeti C. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Euro. Heart J.30(16), 1995–2002 (2009).
   PubMed Web of Science ®Google Scholar
• Lee KJ, McCrindle BW, Bohn DJ et al. Clinical outcomes of acute myocarditis in childhood. Heart82(2), 226–233 (1999).
   PubMed Web of Science ®Google Scholar
• Kleinert S, Weintraub RG, Wilkinson JL et al. Myocarditis in children with dilated cardiomyopathy: incidence and outcome after dual therapy immunosuppression. J. Heart Lung Transplant.16(12), 1248–1254 (1997).
   PubMed Web of Science ®Google Scholar
• Gagliardi MG, Bevilacqua M, Bassano C et al. Long term follow up of children with myocarditis treated by immunosuppression and of children with dilated cardiomyopathy. Heart90(10), 1167–1171 (2004).
   PubMed Web of Science ®Google Scholar
• Haque A, Bhatti S, Siddiqui FJ. Intravenous immune globulin for severe acute myocarditis in children. Indian Pediatr.46(9), 810–811 (2009).
   PubMed Web of Science ®Google Scholar
• Hia CP, Yip WC, Tai BC, Quek SC. Immunosuppressive therapy in acute myocarditis: an 18 year systematic review. Arch. Dis. Child.89(6), 580–584 (2004).
   PubMed Web of Science ®Google Scholar
• Foerster SR, Canter CE, Cinar A et al. Ventricular remodeling and survival are more favorable for myocarditis than for idiopathic dilated cardiomyopathy in childhood: an outcomes study from the pediatric cardiomyopathy registry. Circ. Heart Fail.3(6), 687–697 (2010).
   Google Scholar
• Aziz KU, Patel N, Sadullah T, Tasneem H, Thawerani H, Talpur S. Acute viral myocarditis: role of immunosuppresion: a prospective randomised study. Cardiol. Young20(5), 509–515 (2010).
   PubMed Web of Science ®Google Scholar
• Cooper LT, Hare JM, Tazelaar HD et al. Usefulness of immunosuppression for giant cell myocarditis. J. Cardiol.102(11), 1535–1539 (2008).
   Web of Science ®Google Scholar
• Brunetti L, DeSantis ER. Treatment of viral myocarditis caused by coxsackie B. Am. J. Health Syst. Pharm.65(2), 132–137 (2008).
   PubMed Web of Science ®Google Scholar
• Zimmerman O, Rodewald C, Radermacher M et al. Interferon β-1b therapy in chronic viral dilated cardiomyopathy- is there a role for specific therapy? J. Card. Fail.16(4), 348–356 (2010).
   PubMed Web of Science ®Google Scholar
• Meune C, Spaulding C, Mahe I, Lebon P, Bergmann JF. Risks versus benefits of NSAIDS including aspirin myocarditis: a review of the evidence from animal studies. Drug Saf.26(13), 975–981 (2003).
   PubMed Web of Science ®Google Scholar
• Cabinian AE, Kiel RJ, Smith F, Ho KL, Reves MP. Modification of exercise-aggrivated cosackievirus B3 murine myocarditis by T lymphocyte suppression in an inbred model. J. Lab. Clin. Med.115(4), 454–462 (1990).
   PubMed Web of Science ®Google Scholar
• Miric M, Miskovic A, Brkic S, Vasilievic J, Pesic M. Long-term follow-up of patients with myocarditis and idiopathic dilated cardiomyopathy after immunomodulatory therapy. FEMS Immunol. Med. Microbiol.10(1), 65–74 (1994).
   PubMedGoogle Scholar
• Rajagopal SK, Almond CS, Laussen PC, Rycus PT, Wypij D, Thiagarajan RR. Extracorporeal membrane oxygenation for the support of infants, children, and young adults with acute myocarditis: a review of the Extracorporeal Life Support Organization registry. Crit. Care Med.38(2), 382–387 (2010).
   PubMed Web of Science ®Google Scholar
• Morales DL, Almond CS, Jaquiss RD et al. Bridging children of all sizes to cardiac transplantation: the intial multicenter North American experience with the Berlin Heart EXCOR ventricular assist device. J. Heart Lung Transplant.30(1), 1–8 (2011).
   PubMed Web of Science ®Google Scholar
• Jones CB, Cassidy JV, Kirk R et al. Successful bridge to recovery with 120 days of mechanical support in an infant with myocarditis. J. Heart Lung Transplant.28(2), 202–205 (2009).
   PubMed Web of Science ®Google Scholar
• Wu ET, Huang SC, Chen YS, Wang JK, Wu MH, Ko WJ. Children with fulminant myocarditis rescued with extracorporeal membrane oxygenation. Heart92(9), 1325–1326 (2006).
   PubMed Web of Science ®Google Scholar
• Nahum E, Dagan O, Lev A et al. Favorable outcome of pediatric fulminant myocarditis supported by extracorpeal membranous oxygenation. Pediatr. Cardiol.31(7), 1059–1063 (2010).
   PubMed Web of Science ®Google Scholar
• Asaumi Y, Yasuda S, Morii I et al. Favourable clinical outcome in patients with cardiogenic shock due to fulminant myocarditis supported by percutaneous extracorporeal membrane oxygenation. Eur. Heart J.26(20), 2185–2192 (2005).
   PubMed Web of Science ®Google Scholar
• Reiss N, El-Banayosy A, Arusoglu L et al. Acute fulminant myocarditis in children and adolescents: the role mechanical circulatory assist. ASAIO J.52(2), 211–214 (2006).
   PubMed Web of Science ®Google Scholar
• Romero-Rodriguez N, Lage-Galle E, Guisado-Rasco A et al. Survival after cardiac transplantation: influence of the previous cardiopathy in the recipient. Transplant. Proc.42(8), 3173–3174 (2010).
   PubMed Web of Science ®Google Scholar
• Kirk R, Edwards LB, Kucheryavaya AY et al. The registry of the international society for heart and lung transplantation: thirteenth official pediatric heart transplantation report – 2010. J. Heart Lung Transplant.29(10), 1119–1128 (2010).
   PubMed Web of Science ®Google Scholar
• Pietra BA, Kantor PF, Bartlett HL et al. Clinical factors associated with UNOS status and outcome after listing for heart transplant in children with dilated cardiomyopathy. Circulation116, II_565 (2007) (Abstract 2557).
   Google Scholar
• Drucker NA, Colan SD, Lewis AB et al. Gamma-globulin treatment of acute myocarditis in the pediatric population. Circulation89(1), 252–257 (1994).
   PubMed Web of Science ®Google Scholar
• Miller DV, Krigman H, Canter C. Heart. In: Pathology of Solid Organ Transplant. Liapis H and Wang HL (Eds). Springer-Verlag Publishers, NY, USA, 317–326 (2011).
   Google Scholar